These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19170172)

  • 1. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
    Saleh HA; Aulicino M; Zaidi SY; Khan AZ; Masood S
    Diagn Cytopathol; 2009 Mar; 37(3):184-90. PubMed ID: 19170172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical diagnosis of hepatocellular carcinoma and identification of carcinomas of unknown primary metastatic to the liver on fine-needle aspiration cytologies.
    Onofre AS; Pomjanski N; Buckstegge B; Böcking A
    Cancer; 2007 Aug; 111(4):259-68. PubMed ID: 17567831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration cytology.
    Saad RS; Luckasevic TM; Noga CM; Johnson DR; Silverman JF; Liu YL
    Diagn Cytopathol; 2004 Jan; 30(1):1-6. PubMed ID: 14696137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.
    Karabork A; Kaygusuz G; Ekinci C
    Pathol Res Pract; 2010 Aug; 206(8):572-7. PubMed ID: 20400233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.
    Wang L; Vuolo M; Suhrland MJ; Schlesinger K
    Acta Cytol; 2006; 50(3):257-62. PubMed ID: 16780018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating reactive mesothelial cells from metastatic adenocarcinoma in serous effusions: the utility of immunocytochemical panel in the differential diagnosis.
    Saleh HA; El-Fakharany M; Makki H; Kadhim A; Masood S
    Diagn Cytopathol; 2009 May; 37(5):324-32. PubMed ID: 19191294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver.
    Lin F; Abdallah H; Meschter S
    Diagn Cytopathol; 2004 Feb; 30(2):92-7. PubMed ID: 14755758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
    Nassar A; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
    Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A
    Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B; Boub R; Rahsaz M
    Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican-3 immunocytochemistry in liver fine-needle aspirates : a novel stain to assist in the differentiation of benign and malignant liver lesions.
    Kandil D; Leiman G; Allegretta M; Trotman W; Pantanowitz L; Goulart R; Evans M
    Cancer; 2007 Oct; 111(5):316-22. PubMed ID: 17763368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C; Marsh W; Frankel WL
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An approach to the cytologic diagnostic criteria of hepatocellular carcinoma by fine needle aspiration biopsy].
    Pan Q; Cao J; Teng M
    Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):42-4. PubMed ID: 11776795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Albumin mRNA and pCEA in the histopathologic diagnosis of hepatocellular carcinoma].
    Foschini MP; Macchia S; Baccarini P; Milandri GL; Losi L; Spongano P; Panarelli M; Dal Monte PR; Eusebi V
    Pathologica; 1999 Aug; 91(4):260-7. PubMed ID: 10630075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyclonal carcinoembryonic antigen staining in the cytologic differential diagnosis of primary and metastatic hepatic malignancies.
    Wolber RA; Greene CA; Dupuis BA
    Acta Cytol; 1991; 35(2):215-20. PubMed ID: 1709323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembryonic antigen and naphthylamidase in fine needle aspiration biopsy material.
    Wong MA; Yazdi HM
    Acta Cytol; 1990; 34(2):192-6. PubMed ID: 2157322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
    Röcken C; Licht J; Roessner A; Carl-McGrath S
    J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-needle aspiration cytology to distinguish dysplasia from hepatocellular carcinoma with different grades.
    Lin CC; Lin CJ; Hsu CW; Chen YC; Chen WT; Lin SM
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e146-52. PubMed ID: 17532784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.